Don't want ads? Subscribe or login now.

Abbott Asks For Reconsideration To End Stent FCA Suit

By Bryan Koenig · January 13, 2016, 3:38 PM EST

Abbott Laboratories asked a Texas federal judge Tuesday to rethink her decision forcing the company to face a whistleblower's False Claims Act lawsuit alleging it marketed stents for off-label uses, arguing...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Reconsideration

Case Information

Case Title

USA v. Abbott Laboratories et al

Case Number

3:06-cv-01769

Court

Texas Northern

Nature of Suit

Other Statutes: Other Statutory Actions

Date Filed

September 26, 2006

Recent Articles By Bryan

October 10, 2024
FTC's Final Merger Filings Overhaul Drops Labor Market Look
August 29, 2024
FTC Wants Kroger's Constitution Suit To Follow Merger Case
August 22, 2024
Kroger-Albertsons Wrong On Labor Law In FTC Row: NLRB
August 21, 2024
FTC Fails 1st Test Of Rulemaking Push In Noncompetes Loss
August 20, 2024
Texas Judge Blocks FTC's Impending Ban On Noncompetes
August 19, 2024
Kroger Flips Script, Challenges FTC's Constitutionality
August 15, 2024
Fla.'s The Villages Exempted From FTC Noncompete Ban
August 14, 2024
Nursing Co. Exec Can't Split Up Fraud, Wage-Fixing Charges
August 13, 2024
Kroger Blasts FTC's 'Head-To-Head' Competition Claims
July 30, 2024
FTC Seeks Temporary Kroger-Albertsons Block In Oregon